Georgia-Pacific to Invest $500 Million for New TAD Tissue Machine

A $500 million expansion is underway at Georgia-Pacific's Broadway mill. The investments will significantly enhance the company’s retail consumer tissue and towel business.

Investments include building a new paper machine using through-air-dried (TAD) technology and adding associated converting equipment and infrastructure. The improvements will allow the expansion of Georgia-Pacific’s premium brands and support the growth of current and potential customers’ premium private label brands. It's expected to be complete in 2024.

Over 100 jobs will be created to operate the new complex, in addition to the mill’s 850 current employees. The project will have as many as 500 construction and contract-related workers onsite at the mill throughout the project timeline.

“This truly is an investment in our customers and consumers who value the quality of our products,” said Christian Fischer, Georgia-Pacific president, and chief executive officer. “We appreciate the local community, Brown County, state officials, and all of our employees’ hard work and efforts to continue making our Green Bay Broadway mill more competitive for the long-term.”

The Green Bay Broadway mill currently operates seven paper machines and several converting operations to make bath tissue, paper towels, napkins, and facial tissue for retail and away-from-home use. The capital investment at Georgia-Pacific’s Green Bay facilities has totaled more than $700 million since 2006.

“As a Koch company, our focus is on long-term value creation," said Tim Ellsworth, vice president of Green Bay Operations. “This major investment into our Green Bay facility will help Georgia-Pacific continue our focus on transforming manufacturing equipment and processes that result in better employee safety, environmental performance, reliability, and quality.”

Georgia-Pacific operates seven facilities and employs nearly 2,100 people with total annual compensation and benefits of more than $400 million in Wisconsin.

Back to Tissue360 Newsletter